Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer

International Journal of Oncology

Volumn 48, Issue 6, 2016, Pages 2567-2579

  Liao, Juan ^a   Liu, Ran ^a   Shi, Ya Juan ^a   Yin, Li Hong ^a   Pu, Yue Pu ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Cell cell communication; Esophageal cancer; Exosome; MIR 21

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; MICRORNA 21; NEUTRAL SPHINGOMYELINASE 2; PROGRAMMED CELL DEATH 4 PROTEIN; PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RISK; CELL INVASION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ESOPHAGUS CANCER; EXOSOME; EXTRACELLULAR SPACE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL MOTION; DISEASE COURSE; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84964573643     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3453     Document Type: Article

References (54)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Wang KK and Sampliner RE; Practice Parameters Committee of the American College of Gastroenterology: Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103: 788-797, 2008.
3. Kosaka N, Iguchi H and Ochiya T: Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092, 2010.
4. Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom WN and Pass HI: microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol 8: 1156-1162, 2013.
5. Manterola L, Guruceaga E, Gállego Pérez-Larraya J, González-Huarriz M, Jauregui P, Tejada S, Diez-Valle R, Segura V, Samprón N, Barrena C, et al: A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol 16: 520-527, 2014.
6. Liu R, Liao J, Yang M, Shi Y, Peng Y, Wang Y, Pan E, Guo W, Pu Y and Yin L: Circulating miR-155 expression in plasma: A potential biomarker for early diagnosis of esophageal cancer in humans. J Toxicol Environ Health A 75: 1154-1162, 2012.
7. Ali S, Almhanna K, Chen W, Philip PA and Sarkar FH: Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res 3: 28-47, 2010.
8. Wang HY, Yan LX, Shao Q, Fu S, Zhang ZC, Ye W, Zeng YX and Shao JY: Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing. Clin Chem 60: 773-782, 2014.
9. Cheng L, Sharples RA, Scicluna BJ and Hill AF: Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3: 3, 2014.
10. Ge Q, Zhou Y, Lu J, Bai Y, Xie X and Lu Z: miRNA in plasma exosome is stable under different storage conditions. Molecules 19: 1568-1575, 2014.
11. Salido-Guadarrama I, Romero-Cordoba S, Peralta-Zaragoza O, Hidalgo-Miranda A and Rodríguez-Dorantes M: MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. Onco Targets Ther 7: 1327-1338, 2014.
12. Ramachandran S and Palanisamy V: Horizontal transfer of RNAs: Exosomes as mediators of intercellular communication. Wiley Interdiscip Rev RNA 3: 286-293, 2012.
13. Kosaka N, Yoshioka Y, Hagiwara K, Tominaga N, Katsuda T and Ochiya T: Trash or treasure: Extracellular microRNAs and cell-to-cell communication. Front Genet 4: 173, 2013.
14. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD and Kloecker GH: Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46, 2009.
15. Taylor DD and Gercel-Taylor C: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21, 2008.
16. Tadokoro H, Umezu T, Ohyashiki K, Hirano T and Ohyashiki JH: Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem 288: 34343-34351, 2013.
17. Nouraee N, van Roosbroeck K, Vasei M, Semnani S, Samaei NM, Naghshvar F, Omidi AA, Calin GA and Mowla SJ: Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma. PLoS One 8: e73009, 2013.
18. Singh R, Pochampally R, Watabe K, Lu Z and Mo YY: Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer 13: 256, 2014.
19. Umezu T, Ohyashiki K, Kuroda M and Ohyashiki JH: Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32: 2747-2755, 2013.
20. Liao J, Liu R, Yin L and Pu Y: Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing. Int J Mol Sci 15: 15530-15551, 2014.
21. Han Y, Wei F, Xu X, Cai Y, Chen B, Wang J, Xia S, Hu H, Huang X, Han Y, et al: Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19: 455-457, 2002 (In Chinese).
22. Ji H, Erfani N, Tauro BJ, Kapp EA, Zhu HJ, Moritz RL, Lim JW and Simpson RJ: Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes. Electrophoresis 29: 2660-2671, 2008.
23. Yang M, Chen J, Su F, Yu B, Su F, Lin L, Liu Y, Huang JD and Song E: Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 10: 117, 2011.
24. Tian T, Wang Y, Wang H, Zhu Z and Xiao Z: Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem 111: 488-496, 2010.
25. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452, 2010.
26. Kosaka N, Iguchi H, Yoshioka Y, Hagiwara K, Takeshita F and Ochiya T: Competitive interactions of cancer cells and normal cells via secretory microRNAs. J Biol Chem 287: 1397-1405, 2012.
27. Allgayer H: Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73: 185-191, 2010.
28. Li L, Zhou L, Li Y, Lin S and Tomuleasa C: MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog. J BUON 19: 228-236, 2014.
29. Liu T, Liu Q, Zheng S, Gao X, Lu M, Yang C, Dai F, Sheyhidin I and Lu X: MicroRNA-21 promotes cell growth and migration by targeting programmed cell death 4 gene in Kazakh's esophageal squamous cell carcinoma. Dis Markers 2014: 232837, 2014.
30. Kahlert C and Kalluri R: Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med Berl 91: 431-437, 2013.
31. Lee JK, Park SR, Jung BK, Jeon YK, Lee YS, Kim MK, Kim YG, Jang JY and Kim CW: Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One 8: e84256, 2013.
32. Tetta C, Ghigo E, Silengo L, Deregibus MC and Camussi G: Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 44: 11-19, 2013.
33. Ismail N, Wang Y, Dakhlallah D, Moldovan L, Agarwal K, Batte K, Shah P, Wisler J, Eubank TD, Tridandapani S, et al: Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 121: 984-995, 2013.
34. Shimbo K, Miyaki S, Ishitobi H, Kato Y, Kubo T, Shimose S and Ochi M: Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun 445: 381-387, 2014.
35. Gao J, Zhang Q, Xu J, Guo L and Li X: Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. Chin J Cancer Res 25: 743-748, 2013.
36. Gao W, Xu J, Liu L, Shen H, Zeng H and Shu Y: A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer. Biomed Pharmacother 66: 21-28, 2012.
37. Selcuklu SD, Donoghue MTA and Spillane C: miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37: 918-925, 2009.
38. Wang N, Zhang CQ, He JH, Duan XF, Wang YY, Ji X, Zang WQ, Li M, Ma YY, Wang T, et al: MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci 58: 1863-1870, 2013.
39. Lou Y, Cui Z, Wang F, Yang X and Qian J: miR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells. Clin Invest Med 34: E281, 2011.
40. Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One 9: e103698, 2014.
41. Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M, et al: MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 15: 1915-1922, 2009.
42. Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M and Baba H: Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 119: 1159-1167, 2013.
43. Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 288: 10849-10859, 2013.
44. Ma G, Zhang H, Dong M, Zheng X, Ozaki I, Matsuhashi S and Guo K: Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis and progression of human digestive tract cancers. Tumour Biol 34: 3879-3885, 2013.
45. Wang D, Guo S, Han SY, Xu N, Guo JY and Sun Q: Distinct roles of different fragments of PDCD4 in regulating the metastatic behavior of B16 melanoma cells. Int J Oncol 42: 1725-1733, 2013.
46. Lankat-Buttgereit B and Göke R: The tumour suppressor Pdcd4: Recent advances in the elucidation of function and regulation. Biol Cell 101: 309-317, 2009.
47. Zhang YY, Chen B and Ding YQ: Metastasis-associated factors facilitating the progression of colorectal cancer. Asian Pac J Cancer Prev 13: 2437-2444, 2012.
48. Yadav L, Puri N, Rastogi V, Satpute P, Ahmad R and Kaur G: Matrix metalloproteinases and cancer - roles in threat and therapy. Asian Pac J Cancer Prev 15: 1085-1091, 2014.
49. Dong CG, Wu WK, Feng SY, Wang XJ, Shao JF and Qiao J: Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. Int J Oncol 41: 1005-1012, 2012.
50. Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L and Huang Y: miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 27: 1660-1668, 2012.
51. Jiang Y, Zhang SH, Han GQ and Qin CY: Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma. Biomed Pharmacother 64: 424-429, 2010.
52. Khosravi S, Tam KJ, Ardekani GS, Martinka M, McElwee KJ and Ong CJ: eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion. J Invest Dermatol 135: 1358-1367, 2015.
53. Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, et al: Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One 9: e92921, 2014.
54. Que R, Ding G, Chen J and Cao L: Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol 11: 219, 2013.